How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Keep up the assault, pull back when it burrows under to dodge lightning blast, then refocus your attack when it tries to take ...

Recent insider activity for Recursion Pharmaceuticals Inc included 1 Tax Payment by Ben R Taylor totaling $18,400.36. 1 transaction was reported, and the full verified total matches $18,400.36.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...

MimeKit 5.0 is a major release containing a number of breaking changes. The headline changes are the split of the cryptography support into its own assembly, the promotion of the new MIME parser, a ...